Trademark: 97577537
Word
SENESCEA THERAPEUTICS
Status Date
Tuesday, May 21, 2024
Filing Date
Friday, September 2, 2022
Published for Opposition
Tuesday, May 21, 2024
5 Pharmaceutical and therapeutic agents for use in cellular regeneration and cellular rejuvenation; pharmaceutical and therapeutic agents for the treatment of age-related diseases, and the treatment of degenerative diseases; pharmaceutical and therapeutic agents for use in targeting or regulating senescent cells; pharmaceutical and therapeutic agents designed to directly target and regulate senescent cells for cellular regeneration, cellular rejuvenation to restore cell health, treatment of age-related diseases, treatment of degenerative diseases, anti-aging treatments, treatments to reverse human disease, and treatment of human disease; cells for regenerative medicine for the treatment of age-related diseases, treatment of degenerative diseases, anti-aging, to reverse human disease, and to directly target and regulate senescent cells; clinical medical reagents
1 reagents for research purposes for drug discovery and development; Diagnostic reagents for clinical or medical laboratory use
44 providing health and medical information; providing a website featuring health and medical information
42 medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials
Sep 6, 2022
New Application Entered
Sep 21, 2022
New Application Office Supplied Data Entered
Oct 24, 2022
Teas Voluntary Amendment Received
Oct 24, 2022
Teas Amendment Entered Before Attorney Assigned
Jun 19, 2023
Assigned To Examiner
Jul 3, 2023
Non-Final Action Written
Jul 3, 2023
Non-Final Action E-Mailed
Jul 3, 2023
Notification Of Non-Final Action E-Mailed
Oct 3, 2023
Application Extension To Response Period - Received
Oct 3, 2023
Application Extension Granted/Receipt Provided
Dec 11, 2023
Teas Response To Office Action Received
Dec 11, 2023
Correspondence Received In Law Office
Dec 12, 2023
Teas/Email Correspondence Entered
Jan 9, 2024
Final Refusal Written
Jan 9, 2024
Final Refusal E-Mailed
Jan 9, 2024
Notification Of Final Refusal Emailed
Mar 11, 2024
Teas/Email Correspondence Entered
Mar 11, 2024
Correspondence Received In Law Office
Mar 11, 2024
Teas Request For Reconsideration Received
Mar 28, 2024
Examiners Amendment -Written
Mar 28, 2024
Examiners Amendment E-Mailed
Mar 28, 2024
Notification Of Examiners Amendment E-Mailed
Mar 28, 2024
Examiner's Amendment Entered
Apr 15, 2024
Approved For Pub - Principal Register
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
